James F O's most recent trade in Firstenergy Corp. was a trade of 837 Phantom Stock Units done . Disclosure was reported to the exchange on April 1, 2026.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| FirstEnergy | James F O'Neil | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Apr 2026 | 837 | 45,814 | - | - | Phantom Stock Units | |
| Accelerant Holdings (Class A) | Francis James O’Neill | Co-Founder, Chief U/W Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 18 Mar 2026 | 128,644 | 7,363,769 | - | 0 | Class A Common Shares | |
| FirstEnergy | James F O'Neil | Director | Sale of securities on an exchange or to another person at price $ 50.60 per share. | 11 Mar 2026 | 7,945 | 1,869 (0%) | 0% | 50.6 | 402,041 | Common Stock |
| FirstEnergy | James F O'Neil | Director | Grant, award, or other acquisition of securities at price $ 45.00 per share. | 02 Jan 2026 | 944 | 9,814 (0%) | 0% | 45 | 42,480 | Common Stock |
| Accelerant Holdings (Class A) | Francis James O’Neill | Co-Founder, Chief U/W Officer | Purchase of securities on an exchange or from another person at price $ 13.34 per share. | 18 Nov 2025 | 38,000 | 7,235,125 | - | 13.3 | 506,810 | Class A Common Shares |
| FirstEnergy | James F O'Neil | Director | Grant, award, or other acquisition of securities at price $ 45.93 per share. | 01 Oct 2025 | 925 | 8,870 (0%) | 0% | 45.9 | 42,485 | Common Stock |
| Accelerant Holdings (Class A) | Francis James O’Neill | Co-Founder, Chief U/W Officer | 25 Jul 2025 | 163,616,981 | 0 | - | - | LP Interests of Accelerant Holdings LP | ||
| Accelerant Holdings (Class A) | Francis James O’Neill | Co-Founder, Chief U/W Officer | 25 Jul 2025 | 7,136,705 | 7,136,705 | - | - | Class A Common Shares | ||
| Accelerant Holdings (Class A) | Francis James O’Neill | Co-Founder, Chief U/W Officer | Sale or transfer of securities back to the company at price $ 0.00 per share. | 25 Jul 2025 | 22,190 | 0 | - | - | Redeemable Preference Shares | |
| Accelerant Holdings (Class A) | Francis James O’Neill | Co-Founder, Chief U/W Officer | 25 Jul 2025 | 7,975 | 0 | - | - | Convertible Preference Shares | ||
| Accelerant Holdings (Class A) | Francis James O’Neill | Co-Founder, Chief U/W Officer | 25 Jul 2025 | 7,975 | 7,144,680 | - | - | Class A Common Shares | ||
| Accelerant Holdings (Class A) | Francis James O’Neill | Co-Founder, Chief U/W Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 23 Jul 2025 | 882,611 | 882,611 | - | - | Stock Option (Right to Buy) | |
| FirstEnergy | James F O'Neil | Director | Grant, award, or other acquisition of securities at price $ 40.26 per share. | 01 Jul 2025 | 1,055 | 7,811 (0%) | 0% | 40.3 | 42,474 | Common Stock |
| Nuvectis Pharma Inc | James F. Oliviero | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 Jun 2025 | 30,000 | 87,828 | - | 0 | Common Stock | |
| Checkpoint Therapeutics Inc | James F. Oliviero | Director, CEO, President and Director | 30 May 2025 | 3,759,929 | 0 (0%) | 12% | - | COMMON STOCK | ||
| Checkpoint Therapeutics Inc | James F. Oliviero | Director, CEO, President and Director | Sale of securities on an exchange or to another person at price $ 4.04 per share. | 02 Apr 2025 | 15,090 | 3,759,929 (12%) | 0% | 4.0 | 60,964 | COMMON STOCK |
| FirstEnergy | James F O'Neil | Director | Grant, award, or other acquisition of securities at price $ 40.23 per share. | 01 Apr 2025 | 1,056 | 6,684 (0%) | 0% | 40.2 | 42,483 | Common Stock |
| Checkpoint Therapeutics Inc | James F. Oliviero | Director, CEO, President and Director | Sale of securities on an exchange or to another person at price $ 3.15 per share. | 07 Feb 2025 | 10,331 | 3,775,019 (12%) | 0% | 3.2 | 32,543 | COMMON STOCK |
| Checkpoint Therapeutics Inc | James F. Oliviero | Director, CEO, President and Director | Sale of securities on an exchange or to another person at price $ 3.41 per share. | 07 Feb 2025 | 9,233 | 3,785,350 (12%) | 0% | 3.4 | 31,485 | COMMON STOCK |
| Checkpoint Therapeutics Inc | James F. Oliviero | Director, CEO, President and Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 30 Jan 2025 | 1,500,000 | 3,794,583 (12%) | 4% | 0 | COMMON STOCK (RESTRICTED) | |
| FirstEnergy | James F O'Neil | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Jan 2025 | 1,000 | 42,792 | - | - | Phantom Stock Units | |
| Checkpoint Therapeutics Inc | Oliviero F. James | Director, CEO, President and Director | Gift of securities by or to the insider at price $ 0.00 per share. | 18 Dec 2024 | 900,000 | 2,294,583 (7%) | 2% | 0 | COMMON STOCK | |
| Checkpoint Therapeutics Inc | James F. Oliviero | Director, CEO, President and Director | Sale of securities on an exchange or to another person at price $ 3.87 per share. | 18 Dec 2024 | 602,167 | 3,414,813 (10%) | 1% | 3.9 | 2,330,386 | COMMON STOCK |
| Checkpoint Therapeutics Inc | F. Oliviero James | Director, CEO, President and Director | Sale of securities on an exchange or to another person at price $ 3.38 per share. | 18 Dec 2024 | 220,230 | 3,194,583 (10%) | 0% | 3.4 | 744,377 | COMMON STOCK |
| Checkpoint Therapeutics Inc | James F. Oliviero | Director, CEO, President and Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 13 Dec 2024 | 2,077,700 | 4,016,980 (12%) | 6% | 0 | COMMON STOCK | |
| FirstEnergy | James F O'Neil | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Oct 2024 | 900 | 41,379 | - | - | Phantom Stock Units | |
| FirstEnergy | James F O'Neil | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Jul 2024 | 1,039 | 40,096 | - | - | Phantom Stock Units | |
| Checkpoint Therapeutics Inc | James F. Oliviero | Director, CEO, President and Director | Gift of securities by or to the insider at price $ 0.00 per share. | 26 Jun 2024 | 37,890 | 1,939,280 (6%) | 0% | 0 | COMMON STOCK | |
| Checkpoint Therapeutics Inc | James F. Oliviero | Director, CEO, President and Director | Sale of securities on an exchange or to another person at price $ 2.05 per share. | 26 Jun 2024 | 24,610 | 1,977,170 (6%) | 0% | 2.1 | 50,451 | COMMON STOCK |
| Nuvectis Pharma Inc | James F. Oliviero | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 13 Jun 2024 | 30,000 | 57,828 | - | 0 | Common Stock | |
| Checkpoint Therapeutics Inc | James F. Oliviero | Director, CEO, President and Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 24 May 2024 | 1,660,000 | 2,001,780 (6%) | 5% | 0 | COMMON STOCK (RESTRICTED) | |
| FirstEnergy | James F O'Neil | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Apr 2024 | 1,043 | 38,646 | - | - | Phantom Stock Units | |
| Checkpoint Therapeutics Inc | James F. Oliviero | Director, CEO, President and Director | Gift of securities by or to the insider at price $ 0.00 per share. | 28 Feb 2024 | 9,056 | 341,780 (1%) | 0% | 0 | COMMON STOCK | |
| Checkpoint Therapeutics Inc | James F. Oliviero | Director, CEO, President and Director | Sale of securities on an exchange or to another person at price $ 2.06 per share. | 28 Feb 2024 | 5,894 | 350,836 (1%) | 0% | 2.1 | 12,142 | COMMON STOCK |
| Checkpoint Therapeutics Inc | Oliviero James F. | Director, CEO, President and Director | Gift of securities by or to the insider at price $ 0.00 per share. | 01 Feb 2024 | 12,950 | 356,730 (1%) | 0% | 0 | COMMON STOCK | |
| Checkpoint Therapeutics Inc | Oliviero F. James | Director, CEO, President and Director | Sale of securities on an exchange or to another person at price $ 2.01 per share. | 01 Feb 2024 | 11,900 | 369,680 (1%) | 0% | 2.0 | 23,919 | COMMON STOCK |
| FirstEnergy | F O'Neil James | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Jan 2024 | 1,083 | 37,187 | - | - | Phantom Stock Units | |
| Checkpoint Therapeutics Inc | F. James Oliviero | Director, CEO, President and Director | Gift of securities by or to the insider at price $ 0.00 per share. | 31 Dec 2023 | 42,000 | 381,580 (1%) | 0% | 0 | Common Stock | |
| Checkpoint Therapeutics Inc | F. James Oliviero | Director, CEO, President and Director | 31 Dec 2023 | 12,510 | 381,580 (1%) | 0% | 0 | Common Stock | ||
| FirstEnergy | James F O'Neil | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Oct 2023 | 1,204 | 35,706 | - | - | Phantom Stock Units | |
| FirstEnergy | James F O'Neil | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Jul 2023 | 1,029 | 34,121 | - | - | Phantom Stock Units | |
| Nuvectis Pharma Inc | James F. Oliviero | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 16 Jun 2023 | 18,000 | 27,828 | - | 0 | Common Stock | |
| Air Transport Services Group | James F. O'Grady | Subsidiary President - ATI | Grant, award, or other acquisition of securities at price $ 20.78 per share. | 03 Apr 2023 | 5,800 | 73,712 (0%) | 0% | 20.8 | 120,524 | Common Stock |
| FirstEnergy | James F O'Neil | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Apr 2023 | 1,003 | 32,756 | - | - | Phantom Stock Units | |
| Checkpoint Therapeutics Inc | James F. Oliviero | Director, CEO, President and Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 31 Mar 2023 | 250,000 | 394,090 (1%) | 0% | 0 | COMMON STOCK (RESTRICTED) | |
| Checkpoint Therapeutics Inc | James F. Oliviero | Director, CEO, President and Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 27 Feb 2023 | 15,000 | 149,573 (0%) | 0% | 0 | COMMON STOCK | |
| Checkpoint Therapeutics Inc | James F. Oliviero | Director, CEO, President and Director | Sale of securities on an exchange or to another person at price $ 4.65 per share. | 27 Feb 2023 | 5,548 | 134,573 (0%) | 0% | 4.6 | 25,798 | COMMON STOCK |
| Checkpoint Therapeutics Inc | James F. Oliviero | Director, CEO, President and Director | Sale of securities on an exchange or to another person at price $ 5.00 per share. | 27 Feb 2023 | 5,483 | 144,090 (0%) | 0% | 5 | 27,415 | COMMON STOCK |
| Air Transport Services Group | James F. O'Grady | Subsidiary President - ATI | Grant, award, or other acquisition of securities at price $ 20.96 per share. | 27 Feb 2023 | 3,519 | 67,912 (0%) | 0% | 21.0 | 73,758 | Common Stock |
| Checkpoint Therapeutics Inc | James F. Oliviero | Director, CEO, President and Director | Sale of securities on an exchange or to another person at price $ 4.77 per share. | 01 Feb 2023 | 10,261 | 182,121 (0%) | 0% | 4.8 | 48,945 | COMMON STOCK |
| Checkpoint Therapeutics Inc | James F. Oliviero | Director, CEO, President and Director | Sale of securities on an exchange or to another person at price $ 6.75 per share. | 10 Jan 2023 | 3,817 | 192,382 (0%) | 0% | 6.7 | 25,761 | COMMON STOCK |
| FirstEnergy | James F O'Neil | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Jan 2023 | 1,645 | 31,478 | - | - | Phantom Stock Units | |
| Checkpoint Therapeutics Inc | James F. Oliviero | Director, CEO, President and Director | Gift of securities by or to the insider at price $ 0.00 per share. | 31 Dec 2022 | 60,000 | 196,199 (0%) | 0% | 0 | Common Stock | |
| Air Transport Services Group | James F. O'Grady | Subsidiary President - ATI | Payment of exercise price or tax liability using portion of securities received from the company at price $ 25.98 per share. | 31 Dec 2022 | 1,556 | 64,393 (0%) | 0% | 26.0 | 40,425 | Common Stock |
| FirstEnergy | James F O'Neil | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Oct 2022 | 1,759 | 29,248 | - | - | Phantom Stock Units | |
| FirstEnergy | James F O'Neil | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Jul 2022 | 1,606 | 27,489 | - | - | Phantom Stock Units | |
| Nuvectis Pharma Inc | James F. Oliviero | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Apr 2022 | 15,000 | 15,000 | - | - | Stock Options (right to buy) | |
| FirstEnergy | James F O'Neil | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Apr 2022 | 1,355 | 25,649 | - | - | Phantom Stock Units | |
| Air Transport Services Group | James F. O'Grady | Subsidiary President - ATI | Grant, award, or other acquisition of securities at price $ 33.84 per share. | 25 Mar 2022 | 2,000 | 65,949 (0%) | 0% | 33.8 | 67,680 | Common Stock |
| Air Transport Services Group | James F. O'Grady | Subsidiary President - ATI | Grant, award, or other acquisition of securities at price $ 31.51 per share. | 28 Feb 2022 | 2,333 | 63,949 (0%) | 0% | 31.5 | 73,513 | Common Stock |
| Checkpoint Therapeutics Inc | James F. Oliviero | Director, CEO, President and Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 31 Jan 2022 | 455,000 | 3,608,210 | - | 0 | COMMON STOCK (RESTRICTED) | |
| FirstEnergy | James F O'Neil | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Jan 2022 | 909 | 24,067 | - | - | Phantom Stock Units | |
| FirstEnergy | James F O'Neil | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Oct 2021 | 1,042 | 22,921 | - | - | Phantom Stock Units | |
| FirstEnergy | James F O'Neil | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Jul 2021 | 1,000 | 21,665 | - | - | Phantom Stock Units |